Osman Ersoy

Prof. Dr. Osman Ersoy


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2018 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
MTMustafa Tahtaci
Mustafa Tahtaci
OAOktay ALGIN
Oktay ALGIN
TKTarkan Karakan
Tarkan Karakan
ÖYÖykü Tayfur Yürekli
Öykü Tayfur Yürekli
MAMurat Alisik
Murat Alisik
OEOsman Ersoy
Osman Ersoy
Background/Aims: Pancreatic steatosis (PS) is a generally used term to define accumulation of fat in the pancreas. In theory PS may be able to affect the exocrine function of pancreas. In this study we aimed to determine the effect of PS on exocrine pancreas function. Materials and Methods: Forty-three patients with PS determined by 3 tesla magnetic resonance imaging (MRI) and 48 patients without PS were included in this study. Patients with PS were classified as group 1 and control patients were classified as group 2. Fecal elastase-1 levels were determined. Fecal elastase-1 levels Results: Fecal elastase-1 levels was significantly lower in group 1 compared to group 2 (319.76±45.7 vs 549.31±69.4, respectively, p=0.003). Proportion of patients with EPI was significantly higher in group 1 than group 2 (35.5% vs 12% p=0.042). There were no significant differences in terms of severity or the anatomic distribution of PS in patients with PS with EPI based on MRI (p=0.052, p=0.198, p=0.405) Conclusion: Current study demonstrates that PS can cause EPI. Cite this article as: Tahtacı M, Algın O, Karakan T, et al. Can pancreatic steatosis affect exocrine functions of pancreas? Turk J Gastroenterol 2018; 29: 588-94.

17 September 2015 in Digestion
Verified
Journal Article
Closed access
ABAylin Demirezer Bolat
Aylin Demirezer Bolat
FAFatma Ebru Akın
Fatma Ebru Akın
MTMustafa Tahtaci
Mustafa Tahtaci
ÖYÖykü Tayfur Yürekli
Öykü Tayfur Yürekli
HKHüseyin Köseoğlu
Hüseyin Köseoğlu
OEOsman Ersoy
Osman Ersoy
Aim: To define the prevalence of polyautoimmunity (PAI) among celiac disease (CD) patients and to compare clinical and laboratory features of CD patients with or without PAI in order to determine the risk factors for PAI in CD. Material and Method: Patients diagnosed with CD in our clinic between 2007 and 2014 with at least 1 year of follow-up were retrospectively evaluated. Totally 145 patients were included in the study. Information on patient demographics and laboratory data were obtained from patient records. The study participants were divided into 2 groups. Group 1 was the CD-alone group consisting of patients without any other autoimmune diseases (AIDs), while group 2 was the PAI group consisting of patients with accompanying one or more AIDs. Results: The mean age of 145 CD patients (106 female and 39 male) included in the study was 37.2 ± 12.3 years. Of the 145 patients included, 48 (33.1%) were in the PAI group. When two groups were compared with each other in terms of the demographic features and laboratory data, the following were identified as risk factors for PAI: female gender, family history for AIDs, antigliadin IgG positivity, vitamin D deficiency, antinuclear antibody positivity ≥1/80 titer and having any musculoskeletal disease. Conclusion: To the best of our knowledge, this is one of the largest studies in the literature on CD patients for the PAI prevalence and related risk factors. Identification of the risk factors in early stages is important to explore PAI among CD patients. Larger, prospective studies are warranted about the risk factors and autoimmune characteristics of CD.

15 May 2018 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
HKHüseyin Köseoğlu
Hüseyin Köseoğlu
MAMurat Alisik
Murat Alisik
MBMurat Basaran
Murat Basaran
ÖYÖykü Tayfur Yürekli
Öykü Tayfur Yürekli
TSTevfik Solakoğlu
Tevfik Solakoğlu
ÖEÖzcan EREL
Özcan EREL
Background/Aims: The dynamic thiol/disulfide homeostasis plays pivotal roles in many physiological mechanisms in an organism. We aimed to investigate whether dynamic thiol/disulfide homeostasis changes among patients with acute pancreatitis. Materials and Methods: This prospective trial contained 45 patients with acute pancreatitis and 45 sex-and age-matched healthy volunteers as control group. Thiol/disulfide homeostasis parameters were measured by a novel and automated assay, and detected results were compared between the two groups. Results: Disulfide/total thiol percent ratio and disulfide/native thiol percent ratios were significantly higher in acute pancreatitis group; besides the native thiol, total thiol levels and native thiol/total thiol percent ratios were significantly lower (for all p Conclusion: The thiol/disulfide homeostasis is impaired in acute pancreatitis with a shift toward the oxidative status, and this deficiency might be a pathogenic factor in acute pancreatitis. The correction of this thiol/disulfide imbalance may be a new target in the management of acute pancreatitis. Cite this article as: Köseoğlu H, Alışık M, Başaran M, et al. Dynamic thiol/disulphide homeostasis in acute pancreatitis. Turk J Gastroenterol 2018; 29: 348-53.

7 June 2008 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
OEOsman Ersoy
Osman Ersoy
OHOzgur Harmanci
Ozgur Harmanci
MAMusa Aydinli
Musa Aydinli
BSBulent Sivri
Bulent Sivri
YBYusuf Bayraktar
Yusuf Bayraktar

23 July 2008 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
OEOsman Ersoy
Osman Ersoy
EAEbru Akin
Ebru Akin
SUSerdar Ugras
Serdar Ugras
SBSemnur Buyukasik
Semnur Buyukasik
ESEyup Selvi
Eyup Selvi
GGGüven Güney
Güven Güney

8 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BIBayram Inan
Bayram Inan
AAAHMET AKBAY
AHMET AKBAY
BEBeril Turan Erdogan
Beril Turan Erdogan
ÇEÇağdaş Erdoğan
Çağdaş Erdoğan
IAIhsan Ates
Ihsan Ates
OEOsman Ersoy
Osman Ersoy
Background: Diabetes mellitus (DM) is a condition that may increase the severity of acute pancreatitis (AP) through chronic inflammation and disturbances in immune responses. However, the independent effect of DM on clinical outcomes in AP has not yet been fully elucidated. Methods: In this retrospective cohort study, 492 patients diagnosed with acute pancreatitis at the Gastroenterology Clinic of Ankara Bilkent City Hospital between January 2022 and March 2025 were included. Patients were divided into two groups based on the presence of diabetes, and outcomes were compared using statistical methods. Results: Of the total 492 patients (mean age 58.6 ± 17.2 years; 50.2% female) included, 98 (19.9%) had DM. Moderate-to-severe AP occurred in 67.3% of diabetic versus 37.8% of non-diabetic patients (p < 0.0001), and severe disease developed more frequently in the diabetic group (6.1% vs. 1.0%, p = 0.0057). Systemic complications were significantly more common in patients with diabetes (45.9% vs. 26.9%, p = 0.0004). Hospital mortality was higher among patients with diabetes (9.2% vs. 4.6%, p = 0.0344), and Kaplan–Meier analysis demonstrated numerically lower overall survival in patients with diabetes (log-rank p = 0.095), with early divergence in survival curves. Cox proportional hazards analysis confirmed diabetes as an independent predictor of in-hospital mortality (adjusted HR 2.64, 95% CI 1.17–5.97; p = 0.019). After adjustment for confounders, diabetes remained independently associated with the development of moderate/severe pancreatitis (adjusted OR 2.00, 95% CI 1.24–3.22; p = 0.004). Diabetes also independently predicted in-hospital mortality (adjusted OR 3.36, 95% CI 1.35–8.34; p = 0.009), along with APACHE II score. ROC analysis demonstrated that adding diabetes mellitus to the APACHE II score significantly improved mortality prediction compared with APACHE II alone (AUC 0.785 vs. 0.724). The retrospective and single-center design of this study may limit its generalizability and create potential selection bias. There were insufficient data on the type of diabetes, its duration, and glycemic control (e.g., HbA1c), and therefore, we could not assess these factors, all of which may influence risk estimates. Although the survival curves showed early divergence, the borderline log-rank significance (p = 0.095) highlights the limited statistical power to detect long-term survival differences in this cohort. Conclusions: DM is associated with substantially increased severity and in-hospital mortality in AP, primarily through an elevated risk of systemic organ failure. Incorporation of diabetes status into early severity stratification may improve prognostic accuracy and guide closer monitoring and timely interventions in this high-risk population.